FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Floxuridine for Injection, USP
Status: Currently in Shortage
»Date first posted: 09/16/2020
»Therapeutic Categories: Oncology

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (New 09/16/2020)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg per vial (NDC 0143-9270-01) This presentation is temporarily on backorder. Additional lots are scheduled for manufacturing and will be available in the Late October 2020 timeframe. Product will be made available as it is released. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English